Is XPHYF or DIVO a better dividend investment in 2026?

XPHYF currently yields 705.11% with a 5% 5-year dividend growth rate. DIVO yields 6.62% with 5% growth. The better choice depends on your goal: XPHYF offers higher current income.

What is the dividend yield difference between XPHYF and DIVO?

XPHYF has a forward dividend yield of 705.11% ($2.00/share annually). DIVO yields 6.62% ($2.91/share annually). The yield gap is 698.49 percentage points.

Home › Compare › XPHYF vs DIVO

XPHYF vs DIVO: Dividend Comparison 2026

XPHYF yields 705.11% · DIVO yields 6.62%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 XPHYF wins by $964927.34M in total portfolio value

INVESTMENT

TIME HORIZON10 years

XPHYF

● Live price

705.11%

Share price

$0.28

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$964927.37M

Annual income

$754,446,983,210.15

Full XPHYF calculator →

DIVO

● Live price

6.62%

Share price

$44.00

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.0K

Annual income

$1,008.47

Full DIVO calculator →

Portfolio growth — XPHYF vs DIVO

📍 XPHYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	XPHYF	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, XPHYF + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

XPHYF pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XPHYF

Annual income on $10K today (after 15% tax)

$59,934.07/yr

After 10yr DRIP, annual income (after tax)

$641,279,935,728.63/yr

DIVO

Annual income on $10K today (after 15% tax)

$562.67/yr

After 10yr DRIP, annual income (after tax)

$857.20/yr

At 15% tax rate, XPHYF beats the other by $641,279,934,871.43/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XPHYF + DIVO for your $10,000?

XPHYF: 50%DIVO: 50%

100% DIVO50/50100% XPHYF

Portfolio after 10yr

$482463.70M

Annual income

$377,223,492,109.31/yr

Blended yield

78.19%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XPHYF buys

DIVO buys

No recent congressional trades found for XPHYF or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricXPHYFDIVO

Forward yield	705.11% ✓	6.62%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$964927.37M ✓	$31.0K
Annual income after 10y	$754,446,983,210.15 ✓	$1,008.47
Total dividends collected	$947907.97M ✓	$8.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: XPHYF vs DIVO ($10,000, DRIP)

Year	XPHYF Portfolio	XPHYF Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$81,211	$70,510.67	$11,362	$661.96	+$69.8K → XPHYF
2	$622,056	$535,160.68	$12,860	$702.91	+$609.2K → XPHYF
3	$4,496,642	$3,831,041.55	$14,504	$743.56	+$4.48M → XPHYF
4	$30,693,047	$25,881,640.63	$16,303	$783.73	+$30.68M → XPHYF
5	$197,946,383	$165,104,822.52	$18,268	$823.31	+$197.93M → XPHYF
6	$1,206,941,168	$995,138,538.05	$20,408	$862.17	+$1206.92M → XPHYF
7	$6,962,148,280	$5,670,721,230.88	$22,737	$900.20	+$6962.13M → XPHYF
8	$38,020,642,481	$30,571,143,821.30	$25,266	$937.31	+$38020.62M → XPHYF
9	$196,710,644,881	$156,028,557,426.06	$28,008	$973.42	+$196710.62M → XPHYF
10	$964,927,373,233	$754,446,983,210.15	$30,977	$1,008.47	+$964927.34M → XPHYF

XPHYF vs DIVO: Complete Analysis 2026

XPHYF — Stock

BioNxt Solutions Inc. operates as a bioscience company in Germany, Switzerland, Austria, Israel, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. The company also develops point-of-care diagnostics comprising rapid diagnostics and biosensor screening tests for early detection and the potential for better treatment outcomes, and improved disease management; and COVID-19 PCR diagnostic kit, peri-implantitis oral biosensor, and H1N1 (swine flu) and H5N1 (avian flu) oral biosensors. In addition, it offers analytical testing and consulting services; and engages in the pathogen and oral health diagnostic and screening test, thin film drug formulation, and psychedelic pharmaceutical production and formulation businesses. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. BioNxt Solutions Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

Full XPHYF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this XPHYF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XPHYF vs SCHD XPHYF vs JEPI XPHYF vs O XPHYF vs KO XPHYF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.